Department of Comparative Medicine and Department of Pathology, Integrative Cell Signaling and Neurobiology of Metabolism Program, and the Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut.
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut.
Ann N Y Acad Sci. 2021 Jul;1495(1):55-77. doi: 10.1111/nyas.14566. Epub 2021 Jan 31.
MicroRNAs are small noncoding RNAs that regulate gene expression at the posttranscriptional level. Since many microRNAs have multiple mRNA targets, they are uniquely positioned to regulate the expression of several molecules and pathways simultaneously. For example, the multiple stages of cholesterol metabolism are heavily influenced by microRNA activity. Understanding the scope of microRNAs that control this pathway is highly relevant to diseases of perturbed cholesterol metabolism, most notably cardiovascular disease (CVD). Atherosclerosis is a common cause of CVD that involves inflammation and the accumulation of cholesterol-laden cells in the arterial wall. However, several different cell types participate in atherosclerosis, and perturbations in cholesterol homeostasis may have unique effects on the specialized functions of these various cell types. Therefore, our review discusses the current knowledge of microRNA-mediated control of cholesterol homeostasis, followed by speculation as to how these microRNA-mRNA target interactions might have distinctive effects on different cell types that participate in atherosclerosis.
MicroRNAs 是小的非编码 RNA,可在转录后水平调节基因表达。由于许多 microRNAs 有多个 mRNA 靶标,因此它们能够同时调节多个分子和途径的表达。例如,胆固醇代谢的多个阶段受到 microRNA 活性的强烈影响。了解控制该途径的 microRNAs 的范围对于胆固醇代谢失调的疾病非常重要,尤其是心血管疾病(CVD)。动脉粥样硬化是 CVD 的常见原因,涉及炎症和富含胆固醇的细胞在动脉壁中的积累。然而,几种不同的细胞类型参与动脉粥样硬化,胆固醇动态平衡的干扰可能对这些不同细胞类型的特殊功能产生独特的影响。因此,我们的综述讨论了 microRNA 介导的胆固醇动态平衡控制的当前知识,接着推测这些 microRNA-mRNA 靶标相互作用可能对参与动脉粥样硬化的不同细胞类型产生独特的影响。
Ann N Y Acad Sci. 2021-7
Adv Exp Med Biol. 2015
Biomed Khim. 2016
Atherosclerosis. 2016-3
Thromb Haemost. 2012-1-25
Am J Cardiol. 1986-2-12
J Reprod Med. 1986-6
J Diabet Complications. 1990
Curr Atheroscler Rep. 2021-5-10
Front Biosci (Landmark Ed). 2018-6-1
Mol Cell Biochem. 2025-8-6
Int J Mol Sci. 2025-4-10
J Inflamm Res. 2025-3-17
Cell Biochem Biophys. 2025-2-28
Sovrem Tekhnologii Med. 2023
Int J Mol Sci. 2025-2-6
Front Genet. 2020-7-10
Front Cardiovasc Med. 2020-5-22
Atherosclerosis. 2020-3
Mol Cell Biol. 2020-4-13
Nat Rev Mol Cell Biol. 2019-12-17
Lipids Health Dis. 2019-12-3